317 related articles for article (PubMed ID: 32165419)
1. Terminally Differentiated Effector Memory CD8
Jacquemont L; Tilly G; Yap M; Doan-Ngoc TM; Danger R; Guérif P; Delbos F; Martinet B; Giral M; Foucher Y; Brouard S; Degauque N
J Am Soc Nephrol; 2020 Apr; 31(4):876-891. PubMed ID: 32165419
[TBL] [Abstract][Full Text] [Related]
2. Effector Memory-Expressing CD45RA (TEMRA) CD8
Doan Ngoc TM; Tilly G; Danger R; Bonizec O; Masset C; Guérif P; Bruneau S; Glemain A; Harb J; Cadoux M; Vivet A; Mai HL; Garcia A; Laplaud D; Liblau R; Giral M; Blandin S; Feyeux M; Dubreuil L; Pecqueur C; Cyr M; Ni W; Brouard S; Degauque N; ;
J Am Soc Nephrol; 2022 Dec; 33(12):2211-2231. PubMed ID: 36280286
[TBL] [Abstract][Full Text] [Related]
3. Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8
Leonhard J; Schaier M; Kälble F; Eckstein V; Zeier M; Steinborn A
Front Immunol; 2022; 13():752570. PubMed ID: 35592311
[TBL] [Abstract][Full Text] [Related]
4. Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.
Yap M; Boeffard F; Clave E; Pallier A; Danger R; Giral M; Dantal J; Foucher Y; Guillot-Gueguen C; Toubert A; Soulillou JP; Brouard S; Degauque N
J Am Soc Nephrol; 2014 Aug; 25(8):1856-68. PubMed ID: 24652799
[TBL] [Abstract][Full Text] [Related]
5. The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance.
Süsal C; Alvarez CM; Benning L; Daniel V; Zeier M; Schaier M; Morath C; Speer C
Clin Exp Immunol; 2024 May; 216(3):318-330. PubMed ID: 38393856
[TBL] [Abstract][Full Text] [Related]
6. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection.
Betjes MG; Meijers RW; de Wit EA; Weimar W; Litjens NH
Transplantation; 2012 Jul; 94(1):63-9. PubMed ID: 22691956
[TBL] [Abstract][Full Text] [Related]
7. Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation.
Gerlach UA; Vogt K; Schlickeiser S; Meisel C; Streitz M; Kunkel D; Appelt C; Ahrlich S; Lachmann N; Neuhaus P; Pascher A; Sawitzki B
Transplantation; 2013 Jun; 95(12):1512-20. PubMed ID: 23619734
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.
Macedo C; Walters JT; Orkis EA; Isse K; Elinoff BD; Fedorek SP; McMichael JM; Chalasani G; Randhawa P; Demetris AJ; Zeevi A; Tan H; Shapiro R; Landsittel D; Lakkis FG; Metes D
Transplantation; 2012 Apr; 93(8):813-21. PubMed ID: 22343334
[TBL] [Abstract][Full Text] [Related]
9. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
Betjes MGH; Litjens NHR
PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
[TBL] [Abstract][Full Text] [Related]
11. T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
Fribourg M; Anderson L; Fischman C; Cantarelli C; Perin L; La Manna G; Rahman A; Burrell BE; Heeger PS; Cravedi P
Kidney Int; 2019 Aug; 96(2):436-449. PubMed ID: 31040060
[TBL] [Abstract][Full Text] [Related]
12. Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.
Boer K; de Wit LE; Peters FS; Hesselink DA; Hofland LJ; Betjes MG; Looman CW; Baan CC
Clin Epigenetics; 2016; 8():116. PubMed ID: 27891189
[TBL] [Abstract][Full Text] [Related]
13. Higher Expression of Activated CD8
Boix F; Jimenez-Coll V; Legaz I; Alfaro R; Moya-Quiles MR; Peña-Moral J; Minguela A; Llorente S; Muro M
Front Biosci (Landmark Ed); 2023 Jun; 28(6):119. PubMed ID: 37395036
[TBL] [Abstract][Full Text] [Related]
14. Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation.
Louis K; Macedo C; Bailly E; Lau L; Ramaswami B; Marrari M; Landsittel D; Chang A; Chandran U; Fadakar P; Yamada M; Chalasani G; Randhawa P; Zeevi A; Singh H; Lefaucheur C; Metes D
J Am Soc Nephrol; 2020 Oct; 31(10):2457-2474. PubMed ID: 32723838
[TBL] [Abstract][Full Text] [Related]
15. Characterization of eomesodermin and T-bet expression by allostimulated CD8
Perez-Gutierrez A; Metes DM; Lu L; Hariharan S; Thomson AW; Ezzelarab MB
Clin Exp Immunol; 2018 Nov; 194(2):259-272. PubMed ID: 30246373
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
17. Belatacept-Resistant Rejection Is Associated With CD28
Mathews DV; Wakwe WC; Kim SC; Lowe MC; Breeden C; Roberts ME; Farris AB; Strobert EA; Jenkins JB; Larsen CP; Ford ML; Townsend R; Adams AB
Am J Transplant; 2017 Sep; 17(9):2285-2299. PubMed ID: 28502128
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
19. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
20. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.
Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P
Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
